Eventide Asset Management’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$66.4M Hold
390,829
– – 0.93% 32
2026
Q2
$60.2M Buy
390,829
+33,179
+9% +$5.09M 0.8% 37
2026
Q1
$57M Sell
357,650
-25,441
-7% -$4.28M 0.94% 31
2025
Q4
$61.3M Buy
383,091
+187,779
+96% +$22.2M 0.96% 27
2025
Q3
$14.5M Buy
+195,312
New +$12.8M 0.24% 114

Other funds holding BLTE

Eventide Asset Management's BLTE Position: Q3 2026 in Review

Eventide Asset Management held its Belite Bio (BLTE) position steady in Q3 2026 at 390,829 shares worth $66.4M. The position accounts for 0.93% of the portfolio, ranked #32.

Eventide Asset Management first reported a position in BLTE in Q3 2025 and has held it in 5 quarters since. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Eventide Asset Management held 390,829 shares of Belite Bio worth $66.4M as of Q3 2026.
  • Eventide Asset Management left its Belite Bio share count unchanged in Q3 2026.
  • Belite Bio made up 0.93% of Eventide Asset Management's portfolio in Q3 2026, its #32 holding.
  • Eventide Asset Management first reported a position in Belite Bio in Q3 2025 and has held it in 5 quarters since.
  • 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Eventide Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.